| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444198 | European Journal of Cancer | 2013 | 9 Pages |
Abstract
In conclusion, in HPVDNA+ and/or HPVDNA+ p16INK4a+ tumours high CD8+ TIL counts indicated a better 3-year OS. This suggests that high CD8+ TIL counts together with HPVDNA+ or HPVDNA+ p16INK4a+ could be used when selecting patients for more individualised treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Cecilia Nordfors, Nathalie Grün, Nikolaos Tertipis, Andreas Ãhrlund-Richter, Linnea Haeggblom, Lars Sivars, Juan Du, Tommy Nyberg, Linda Marklund, Eva Munck-Wikland, Anders Näsman, Torbjörn Ramqvist, Tina Dalianis,